Please assess the completion status of the following clinical trial:

Trial Title: Daytime Corneal Swelling During Wear of Narafilcon B Lenses

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Be of legal age (i.e. ≥ 18 years).~* Be mentally competent, willing and able to sign a written informed consent form.~* Have contact lens distance sphere requirement in the range -1.00D to -6.00D.~* Have spectacle astigmatism \<1.25D in each eye.~* Currently wear soft contact lenses (for at least 6 months prior to the trial) with documentation of current prescription.~* Have normal eyes with no evidence of abnormality or disease. For the purpose of this study a normal eye is defined as one having: i) no evidence of lid abnormality or infection; ii) no conjunctival abnormality or infection; iii) no clinically significant slit lamp findings (i.e, edema, staining, scarring, vascularization, infiltrates or abnormal opacities); iv) no other active ocular disease.~Exclusion Criteria:~* Required concurrent ocular medication.~* Any systemic illness which would contra-indicate lens wear or the medical treatment of which would affect vision or successful lens wear.~* Eye injury or surgery within eight weeks immediately prior to enrollment for this study.~* Abnormal lacrimal secretions.~* Pre-existing ocular irritation that would preclude contact lens fitting.~* Keratoconus or other corneal irregularity.~* Pregnancy, lactating or planning a pregnancy at the time of enrollment.~* Participation in any concurrent clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Spectacles No Lenses (Type: PLACEBO_COMPARATOR): Assigned in random order during one of four 8 hour sessions on four separate days, in one of 24 possible order combinations.
- narafilcon B (Type: EXPERIMENTAL): Assigned in random order during one of four 8 hour sessions on four separate days, in one of 24 possible order combinations.
- polymacon (Type: ACTIVE_COMPARATOR): Assigned in random order during one of four 8 hour sessions on four separate days, in one of 24 possible order combinations.
- lotrafilcon A (Type: ACTIVE_COMPARATOR): Assigned in random order during one of four 8 hour sessions on four separate days, in one of 24 possible order combinations.

Based on this trial design, predict the completion outcome and termination type (if applicable).